Your browser doesn't support javascript.
loading
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification.
Siegenthaler, F; Lindemann, K; Epstein, E; Rau, T T; Nastic, D; Ghaderi, M; Rydberg, F; Mueller, M D; Carlson, J; Imboden, S.
Afiliación
  • Siegenthaler F; Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Switzerland. Electronic address: Franziska.siegenthaler@insel.ch.
  • Lindemann K; Department of Gynecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
  • Epstein E; Department of Clinical Science and Education, Karolinska Institutet, Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.
  • Rau TT; Institute of Pathology, University of Bern, Bern, Switzerland.
  • Nastic D; Department of Oncology-Pathology, Karolinska Institutet, Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Ghaderi M; Department of Oncology-Pathology, Karolinska Institutet, Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Rydberg F; Department of Oncology-Pathology, Karolinska Institutet, Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Mueller MD; Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Carlson J; Department of Oncology-Pathology, Karolinska Institutet, Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Imboden S; Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Switzerland.
Gynecol Oncol ; 165(2): 230-238, 2022 05.
Article en En | MEDLINE | ID: mdl-35277281

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Endometriales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Neoplasias Endometriales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos